Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
about
Venous thromboembolic diseaseImaging Diagnosis of Splanchnic Venous Thrombosis.Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysisSuccessful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature.Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies.Splanchnic vein thrombosis following renal transplantation: a case report.The JAK2 46/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies.Imbalance of pro- vs. anti-coagulation factors in Chinese patients with Budd-Chiari syndrome and non-cirrhotic portal vein thrombosisPharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysis.Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction.Repeated pancreatitis-induced splenic vein thrombosis leads to intractable gastric variceal bleeding: A case report and review.Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational StudySplenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients.Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study.Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.Special indications for vitamin K antagonists: a review.Oxygen in the regulation of intestinal epithelial transport.Research status of Budd-Chiari syndrome in China.The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis.Portal Vein Thrombosis: Recent Advance.Predictive factors of splanchnic vein thrombosis in acute pancreatitis: A 6-year single-center experience.Hepatic encephalopathy associated with cancer or anticancer therapy.Portal vein thrombosis after laparoscopic total colectomy for colonic inertia.Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America.Polycythemia vera: gender-related phenotypic differences.The differential diagnosis of splachnic vein thrombosis.Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms.Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH.Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis.Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?Hereditary and Acquired Thrombophilia in Splanchnic Vein Thrombosis: A Single-Center Experience.Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.
P2860
Q24631121-A2E9F817-48CE-413D-A168-00B15CFB892DQ26776260-FB4C9C99-0CB9-4E0A-8886-96A1874892E4Q28082873-222D8EAF-68C8-49A8-AB2F-B3F50F487641Q33405047-706C4638-9B6B-484E-ACE3-E7DEB21DD467Q33414386-B190B91D-E529-4ED1-8F6D-E8EDC1B3EC49Q34036854-C229FB82-4438-429C-97AE-76442CD22A63Q34502105-DEF51047-67C7-417D-8D2D-0E0D17CC8780Q34857054-3EDD2C02-EAC2-4E26-82A3-AFA1B6DDF2C1Q35205659-3D343DB2-3462-4B00-AC95-BCDF02BDBFEDQ35231004-25CEE583-87D6-43CE-90F4-395463A9B650Q35268361-E10B4265-9CDC-4DD7-A03E-1A567F3E1ABFQ35958807-5BA75663-7BEC-4C94-A46B-45AF4FFB1E9DQ36167786-ACC7EB38-526B-4819-B5F3-BFCF1F16DAEAQ36733711-A4562EED-A5E3-44B3-B31A-8FE43DE2867FQ37130289-43066B31-5560-4538-B731-A63F9C0BEB89Q37317488-1697BE8A-A7C9-43B9-ACFD-40312E024252Q37489987-D050C961-B83B-4C5E-9111-CFF81EAE356AQ37850350-A1D933BC-FEC7-492F-8C13-E5E6509FA8D2Q38202849-9244EDCE-BA15-442A-8739-191A5A5F5270Q38348864-DBBB0B73-ECCD-4066-8684-D7F1662BC39BQ38693795-5CDB73EC-4872-4E94-9693-91300C270199Q38957283-DF6A5435-7FC5-41E7-838C-BD5A8E5A2BA2Q40380577-3CFFB6AA-8C68-4DFF-B96B-19E25469FCA8Q41111818-C06B8916-EABB-48CF-A502-9B806FECA946Q41116744-F2FFCE0D-B79B-4C13-B6A4-B674A18BA07BQ44247861-8AE5EA47-DC29-4DF4-9B54-3347A63C8A35Q45358403-EF133A33-F849-49AD-9AF4-7B687FFB4BD7Q45863547-DA43AB25-D45B-4E66-9713-FA969CC8F73FQ45874680-8DF9FFA6-FB52-4DF5-A356-AB98E96A17FBQ46915951-4F97F0D9-2A8B-4F5E-AC7D-D20C5A09DA48Q47789492-A52C8B61-3F6E-4E68-B2BB-461EA5B5432DQ50086963-F8E909B9-F5C6-4E00-B910-E4A8DEF894A6Q51048904-0DB62A56-1064-468B-AA2B-178282D96D20Q53783646-398E671D-6241-4D3E-B7A1-A90B26C6E2C0Q54568668-45DD37A8-687F-4161-B87D-E7F22C712231Q55286559-2002D99C-798C-4B52-A110-4510CAA04702
P2860
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
@en
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
@nl
type
label
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
@en
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
@nl
prefLabel
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
@en
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
@nl
P2860
P1476
Splanchnic vein thrombosis: clinical presentation, risk factors and treatment
@en
P2093
Ida Martinelli
Valerio De Stefano
P2860
P2888
P304
P356
10.1007/S11739-010-0413-6
P577
2010-06-08T00:00:00Z